Garcia, Kyle O.

HRN: 26-69-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2026
CEFTRIAXONE 1G (VIAL)
02/17/2026
02/24/2026
IV
820MG
OD
LARYNGOTRACHEOBRONCHITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: